IRCT20230910059396N1招募中3 期
Comprehensive evaluation of lisedexamfetamine dimesylate in tratment of binge eating disorder alone and in combination with topiramte in 18_55 year_old edults
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Participants aged 18-55 years old meeting the diagnostic criteria for BED according to DSM-5
排除标准
- •Posing other major psychiatric disorders assessed by psychiatris (anxiety ,depression,..)
- •Posing physical disease like cardiovascular diseases, thyroid disturbances or gastrointestinal diseases
- •known sensitivity to LDX or TPM.
研究者
相似试验
招募中
3 期
Assessment of the effect of lisdexamfetamine on fatigue in patients with multiple sclerosisMultiple sclerosisIRCT20230125057221N1Tehran University of Medical Sciences52
尚未招募
4 期
Oral Lisdexamfetamine for the treatment of Acute Methamphetamine withdrawal (the OLAM trial): A randomised controlled trialACTRN12624001061527St Vincent's Hospital Sydney184
已完成
4 期
Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and AutismAutism Spectrum DisorderAttention Deficit Hyperactivity DisorderNCT03337646JPM van Stralen Medicine Professional48
已完成
4 期
Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder ComorbidityAdult Attention Deficit Hyperactivity Disorder (ADHD) With Co-occuring Anxiety and Depressive DisordersNCT01863459Centre for Anxiety, Attention Deficit and Trauma, Ontario, Canada42
尚未招募
2 期
Influence of Lisdexamfetamine Mesilate (Vyas) in the treatment of premature ejaculatioPremature ejaculationIRCT20160523028008N10Research center for behavioral disorders and substance abuse, Hamadan university of medical sciences46